# Sevoflurane and Hyperperfusion Syndrome

> **NCT02510586** · NA · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 152 (estimated)

## Conditions studied

- Hyperperfusion Syndrome
- Moyamoya Disease

## Interventions

- **DRUG:** Sevoflurane

## Key facts

- **NCT ID:** NCT02510586
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-08
- **Primary completion:** 2018-08
- **Final completion:** 2018-09
- **Target enrollment:** 152 (ESTIMATED)
- **Last updated:** 2015-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02510586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02510586, "Sevoflurane and Hyperperfusion Syndrome". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02510586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*